Hazlett, Burt & Watson’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDX
ACA
CIA
CAI
SIC
KA
Hazlett, Burt & Watson's IBDX Position: Q2 2026 in Review
Hazlett, Burt & Watson sold out of iShares iBonds Dec 2032 Term Corporate ETF (IBDX) in Q2 2026, closing a stake of 157 shares — an estimated $4K sold.
Hazlett, Burt & Watson first reported a position in IBDX in Q3 2025 and held it in 3 quarters. The position peaked at $4K in Q1 2026. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.
- Hazlett, Burt & Watson reported no remaining iShares iBonds Dec 2032 Term Corporate ETF position as of Q2 2026 after selling out during the quarter.
- Hazlett, Burt & Watson sold 157 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $4K.
- Hazlett, Burt & Watson first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q3 2025 and held it in 3 quarters.
- Hazlett, Burt & Watson's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $4K in Q1 2026.
- 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.
Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.